Divis Laboratories Ltd | DIVI - Ebitda

Stock Price
6,760.50
Daily Change
-161.00 -2.33%
Monthly
7.42%
Yearly
7.66%
Q2 Forecast
6,560.86

Divis Laboratories Ltd reported INR8.9B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Aurobindo Pharma INR 17.73B 952.4M Dec/2025
Avita Medical AUD -9.69M 12.21M Dec/2025
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Divis Laboratories Ltd INR 8.9B 20M Dec/2025
Ionis Pharmaceuticals USD -200.02M 42.89M Dec/2025
IQVIA Holdings USD 932M 114M Mar/2026
Lupin INR 23.09B 318.5M Dec/2025
Moderna USD -790M 582M Dec/2025
Organon & Co USD 415M 32M Mar/2026
Revvity USD 272.91M 24M Mar/2026
Tectonic Therapeutic USD -21.18M 365K Dec/2025
Tilray USD 8.36M 1.82M Sep/2025
Viatris USD 1.05B 46.4M Mar/2026
Xeris Pharmaceuticals USD 25.09M 7.67M Dec/2025